Gennova Biopharmaceuticals Develops Omicron-specific mRNA-based Booster Vaccine
GG News Bureau
New Delhi, 20th June. The Department of Biotechnology (DBT) has announced that the Omicron-specific mRNA-based Booster vaccine developed using the indigenous platform technology by Gennova Biopharmaceuticals Ltd. and…